Breaking News Instant updates and real-time market news.

AKAO

Achaogen

$10.79

0.56 (5.47%)

, PFE

Pfizer

$35.28

0.61 (1.76%)

07:14
02/07/18
02/07
07:14
02/07/18
07:14

Achaogen price target raised to $31 from $25 at H.C. Wainwright

H.C. Wainwright analyst Ed Arce raised his price target for Achaogen (AKAO) to $31 after the FDA classified the outcome of its Q4 reinspection of Pfizer's (PFE) McPherson, Kansas facility as Voluntary Action Indicated. The news provides a clear regulatory path for approval of plazomicin out of the McPherson facility, Arce tells investors in a research note. He views the outcome as an "important risk-reducing development" that removes an overhang on Achaogen shares. The analyst keeps a Buy rating on the name.

AKAO

Achaogen

$10.79

0.56 (5.47%)

PFE

Pfizer

$35.28

0.61 (1.76%)

  • 08

    Feb

  • 12

    Feb

  • 16

    Feb

  • 08

    Mar

  • 25

    Jun

AKAO Achaogen
$10.79

0.56 (5.47%)

09/07/17
EAMC
09/07/17
INITIATION
Target $9
EAMC
Sell
Achaogen initiated with a Sell at Empire (pre-open)
Empire Asset Management analyst Cathy Reese last night started Achaogen with a Sell rating and $9 price target.
10/09/17
LEER
10/09/17
NO CHANGE
Target $22
LEER
Outperform
Achaogen price target lowered to $22 from $28 at Leerink
Leerink analyst Paul Matteis lowered his price target for Achaogen to $22 from $28 on valuation and to reflect increasing competition in carbapenem-resistant enterobacteriaceae. The analyst reiterates an Outperform rating on the shares.
11/09/17
HCWC
11/09/17
NO CHANGE
Target $25
HCWC
Buy
Achaogen price target lowered to $25 from $29 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce lowered his price target for Achaogen to $25 following the company's Q3 results. The analyst, however, remains positive on the prospects of commercial success for plazomicin. He keeps a Buy rating on Achaogen.
01/03/18
RHCO
01/03/18
NO CHANGE
Target $27
RHCO
Buy
Achaogen price target lowered to $27 from $31 at SunTrust
SunTrust analyst Edward Nash lowered his price target on Achaogen to $27 and kept his Buy rating. Nash says the FDA acceptance of filing for the NDA for plazomicin for the treatment of cUTI was no surprise, attributing his price target reduction to the longer pull-through for the drug with the assumption of a "more conservative launch".
PFE Pfizer
$35.28

0.61 (1.76%)

11/13/17
BMOC
11/13/17
NO CHANGE
BMOC
BMO says Pfizer buying Biogen makes more sense than deal for Bristol-Myers
BMO Capital analyst Alex Arfaei noted the "significant market speculation" that Pfizer (PFE) is preparing to execute a large M&A deal. While many sources, including Bloomberg, have speculated that Pfizer could target Bristol-Myers (BMY), Arfaei argues that a deal for Biogen (BIIB) would make more sense. He believes Pfizer has a significant gap in neurology, particularly in Alzheimer's, where it cannot afford to remain on the sidelines as its peers - including Biogen, Merck (MRK), AstraZeneca (AZN), and Eli Lilly (LLY) - all have pivotal trials in that area reading out in 2019-2020. Pfizer could have an opportunity to leverage near-term volatility in Biogen's MS franchise to strike a deal during the next 6-9 months before a potential interim look on aducanumab, which Arfaei views as the strongest of the next wave of Alzheimer's drugs in development, he tells investors.
11/14/17
WELS
11/14/17
NO CHANGE
Target $12
WELS
Outperform
Pfizer ADHD drug supply shortage is positive for Neos, says Wells Fargo
Wells Fargo analyst David Maris says Pfizer (PFE) has sent a letter on physicians dated November 8th telling them of a supply shortage for its liquid and chewable methylphenidate ADHD products. Maris says Pfizer's product is a direct competitor of Neos' (NEOS) recently-launched Cotempla XR-ODT, adding Neos will benefit from having its primary competition in the alternative dose market facing a shortage. The analyst says Cotempla XR-ODT, launched in September, is off to a very strong start, keeping his Outperform rating with a $12 price target on Neos.
12/05/17
SBSH
12/05/17
NO CHANGE
Target $72
SBSH
Buy
Senate tax bill raises odds of Pfizer buying Bristol-Myers, says Citi
The Senate tax bill, which lowers the cost of bringing cash back home from outside the U.S., increases the probability of the "often-discussed" potential acquisition of Bristol-Myers Squibb (BMY) by Pfizer, Citi analyst Andrew Baum tells investors in a research note. The analyst points out that Pfizer has repeatedly underscored the importance of tax reform both from a competitive angle as well as from a merger perspective. Further, the analyst says that while Roche's (RHHBY) IMpower 150 Tecentriq lung cancer data in Geneva will take center stage this week, Bristol-Myers should benefit from two recent positive developments. The FDA's and Centers for Medicare and Medicaid Services' recommendation of Tumor Mutational Burden testing for lung cancer and other tumors will likely materially accelerate adoption and create more favorable reimbursement, Baum writes in a research note partially titled "Stars Converging for BMY." The analyst keeps a Buy rating on Bristol shares with a $72 price target. The stock closed yesterday down 76c to $62.47.
01/29/18
RHCO
01/29/18
NO CHANGE
Target $40
RHCO
Hold
Pfizer price target raised to $40 from $33 at SunTrust
SunTrust analyst John Boris raised his price target on Pfizer to $40 and kept his Hold rating ahead of this week's earnings. The analyst attributes the price outlook revision to the positive impact of the tax changes, but notes that "transformative large-scale M&A" is needed to bring about return to "robust" long-term growth.

TODAY'S FREE FLY STORIES

TSE

Trinseo

$81.05

-0.3 (-0.37%)

16:44
02/19/18
02/19
16:44
02/19/18
16:44
Earnings
Trinseo reports Q4 adjusted EPS $2.14, consensus $2.06 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

XOM

Exxon Mobil

$76.54

0.33 (0.43%)

16:37
02/19/18
02/19
16:37
02/19/18
16:37
Periodicals
Exxon Mobil acquires 2.5% stake in BTC oil pipeline, Reuters reports »

Exxon Mobil has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$183.68

-3.77 (-2.01%)

, TCEHY

Tencent

$58.22

-0.4 (-0.68%)

16:31
02/19/18
02/19
16:31
02/19/18
16:31
Periodicals
Alibaba, Tencent on $10B retail battle, Reuters reports »

Alibaba (BABA) and…

BABA

Alibaba

$183.68

-3.77 (-2.01%)

TCEHY

Tencent

$58.22

-0.4 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

DDAIF

Daimler AG

$90.29

0.37 (0.41%)

16:27
02/19/18
02/19
16:27
02/19/18
16:27
Periodicals
Mercedes-Benz cars' software designed to pass emissions test, Bloomberg reports »

U.S. investigators…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$172.43

-0.56 (-0.32%)

16:18
02/19/18
02/19
16:18
02/19/18
16:18
Periodicals
Apple iPhone losing out to Chinese devices in Asia, WSJ reports »

Apple's iPhone X…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

BLK

BlackRock

$541.10

0.45 (0.08%)

16:13
02/19/18
02/19
16:13
02/19/18
16:13
Periodicals
BlackRock upgrades outlook for stocks on earnings momentum, Reuters says »

BlackRock upgraded its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 01

    Mar

  • 06

    Mar

  • 07

    Mar

  • 23

    Apr

FB

Facebook

$177.36

-2.6 (-1.44%)

16:06
02/19/18
02/19
16:06
02/19/18
16:06
Periodicals
Facebook increasing security team size following Russia indictment, Axios says »

Facebook reiterated it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

SNHY

Sun Hydraulics

$55.48

-0.74 (-1.32%)

16:02
02/19/18
02/19
16:02
02/19/18
16:02
Hot Stocks
Sun Hydraulics announces acquisition of Faster Group »

Sun Hydraulics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

CCL

Carnival

$69.50

-0.1 (-0.14%)

15:59
02/19/18
02/19
15:59
02/19/18
15:59
Hot Stocks
Carnival Fascination resumes year-round service from San Juan »

Carnival Fascination…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

LUV

Southwest

$58.27

0.09 (0.15%)

15:58
02/19/18
02/19
15:58
02/19/18
15:58
Hot Stocks
Southwest Cargo team to begin shipping internationally in spring 2018 »

Southwest Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$116.16

-0.03 (-0.03%)

15:55
02/19/18
02/19
15:55
02/19/18
15:55
Hot Stocks
PPG appoints senior business director, mobility »

PPG announced that Ranju…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUB

Cubic

15:51
02/19/18
02/19
15:51
02/19/18
15:51
Hot Stocks
Cubic announces semiannual dividend »

Cubic announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 14

    Jun

CREE

Cree

$36.71

0.21 (0.58%)

15:48
02/19/18
02/19
15:48
02/19/18
15:48
Hot Stocks
Cree names Thomas Wessel as senior vice president of Global Sales and Marketing »

Cree announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

DB

Deutsche Bank

$16.08

-0.03 (-0.19%)

13:59
02/19/18
02/19
13:59
02/19/18
13:59
Upgrade
Deutsche Bank rating change at BofA/Merrill »

Deutsche Bank upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 25

    Feb

MNLO

Menlo Therapeutics

$34.88

-0.44 (-1.25%)

13:59
02/19/18
02/19
13:59
02/19/18
13:59
Initiation
Menlo Therapeutics initiated at Guggenheim »

Menlo Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHPG

Shire

$134.06

-1.24 (-0.92%)

13:58
02/19/18
02/19
13:58
02/19/18
13:58
Downgrade
Shire rating change at JPMorgan »

Shire downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 23

    Mar

  • 25

    Mar

CVR

Chicago Rivet & Machine

$31.62

-0.0725 (-0.23%)

13:48
02/19/18
02/19
13:48
02/19/18
13:48
Hot Stocks
Chicago Rivet & Machine announces increase in quarterly cash dividend »

On February 19, 2018 the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBL

Noble Energy

$26.28

-0.09 (-0.34%)

13:46
02/19/18
02/19
13:46
02/19/18
13:46
Hot Stocks
Noble announces execution of gas sales agreements for export of gas to Egypt »

Noble Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

TOT

Total

$57.13

0.29 (0.51%)

13:43
02/19/18
02/19
13:43
02/19/18
13:43
Hot Stocks
Total signs definitive agreements with Borealis, NOVA Chemicals to form JV »

Total, Borealis and NOVA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYY

Sysco

$60.00

0.63 (1.06%)

13:39
02/19/18
02/19
13:39
02/19/18
13:39
Hot Stocks
Sysco acquires Doerle Food Services »

Sysco announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 30

    May

SBGI

Sinclair Broadcast

$36.30

-0.95 (-2.55%)

, CMCSA

Comcast

$39.79

-0.29 (-0.72%)

13:36
02/19/18
02/19
13:36
02/19/18
13:36
Hot Stocks
Sinclair announces renewals of NBC affiliation agreements »

Sinclair Broadcast (SBGI)…

SBGI

Sinclair Broadcast

$36.30

-0.95 (-2.55%)

CMCSA

Comcast

$39.79

-0.29 (-0.72%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

  • 05

    Mar

III

Information Services

$4.24

-0.02 (-0.47%)

13:33
02/19/18
02/19
13:33
02/19/18
13:33
Hot Stocks
Information Services releases first client-facing mobile app »

Information Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

  • 29

    Mar

  • 12

    Apr

CAT

Caterpillar

$156.29

-3.69 (-2.31%)

13:24
02/19/18
02/19
13:24
02/19/18
13:24
Hot Stocks
Tony Fassino appointed vice president of Caterpillar's BCP division »

Caterpillar announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$102.49

-0.16 (-0.16%)

13:22
02/19/18
02/19
13:22
02/19/18
13:22
Hot Stocks
Celanese CFO Chris Jensen steps down, Scott Richardson to succeed »

Celanese announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 30

    May

WOR

Worthington

$46.70

0.57 (1.24%)

, JPM

JPMorgan

$114.68

-0.83 (-0.72%)

13:18
02/19/18
02/19
13:18
02/19/18
13:18
Hot Stocks
Worthington extends existing $500M revolving credit facility »

Worthington Industries…

WOR

Worthington

$46.70

0.57 (1.24%)

JPM

JPMorgan

$114.68

-0.83 (-0.72%)

PNC

PNC Financial

$159.08

-0.78 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 25

    Feb

  • 27

    Feb

  • 07

    Mar

  • 13

    Mar

  • 13

    Apr

  • 13

    Apr

  • 30

    May

  • 13

    Jul

  • 14

    Jul

  • 12

    Oct

  • 12

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.